CD8A and neoplasm: In order to confirm the status of TIRs expression upon tumor cell-mediated antigen exposure during the killing assay, gene-edited 3KO MH and OT-1 CD8+ T cells, respectively, were isolated, stained for PD-1, LAG-3, and TIM-3 and subjected to analysis by flow cytometry.